Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Axon injury/loss, demyelination and inflammation are the primary pathologies in multiple sclerosis lesions. Despite the prevailing notion that axon/neuron loss is the substrate of clinical progression of multiple sclerosis, the roles that these individual pathological processes play in multiple sclerosis progression remain to be defined. An imaging modality capable to effectively detect, differentiate and individually quantify axon injury/loss, demyelination and inflammation, would not only facilitate the understanding of the pathophysiology underlying multiple sclerosis progression, but also the assessment of treatments at the clinical trial and individual patient levels. In this report, the newly developed diffusion basis spectrum imaging was used to discriminate and quantify the underlying pathological components in multiple sclerosis white matter. Through the multiple-tensor modelling of diffusion weighted magnetic resonance imaging signals, diffusion basis spectrum imaging resolves inflammation-associated cellularity and vasogenic oedema in addition to accounting for partial volume effects resulting from cerebrospinal fluid contamination, and crossing fibres. Quantitative histological analysis of autopsied multiple sclerosis spinal cord specimens supported that diffusion basis spectrum imaging-determined cellularity, axon and myelin injury metrics closely correlated with those pathologies identified and quantified by conventional histological staining. We demonstrated in healthy control subjects that diffusion basis spectrum imaging rectified inaccurate assessments of diffusion properties of white matter tracts by diffusion tensor imaging in the presence of cerebrospinal fluid contamination and/or crossing fibres. In multiple sclerosis patients, we report that diffusion basis spectrum imaging quantitatively characterized the distinct pathologies underlying gadolinium-enhanced lesions, persistent black holes, non-enhanced lesions and non-black hole lesions, a task yet to be demonstrated by other neuroimaging approaches. Diffusion basis spectrum imaging-derived radial diffusivity (myelin integrity marker) and non-restricted isotropic diffusion fraction (oedema marker) correlated with magnetization transfer ratio, supporting previous reports that magnetization transfer ratio is sensitive not only to myelin integrity, but also to inflammation-associated oedema. Our results suggested that diffusion basis spectrum imaging-derived quantitative biomarkers are highly consistent with histology findings and hold promise to accurately characterize the heterogeneous white matter pathology in multiple sclerosis patients. Thus, diffusion basis spectrum imaging can potentially serve as a non-invasive outcome measure to assess treatment effects on the specific components of underlying pathology targeted by new multiple sclerosis therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenkinson, M., Bannister, P., Brady, M., & Smith, S. (2002) · NeuroImage · doi:10.1006/nimg.2002.1132 · Cited by 11,888
Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water
Song, S.-K., Sun, S.-W., Ramsbottom, M. J., Chang, C., Russell, J., & Cross, A. H. (2002) · NeuroImage · doi:10.1006/nimg.2002.1267 · Cited by 2,582
Self-citationTuch, D. S. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20279 · Cited by 1,880
Song, S.-K., Sun, S.-W., Ju, W.-K., Lin, S.-J., Cross, A. H., & Neufeld, A. H. (2003) · NeuroImage · doi:10.1016/j.neuroimage.2003.07.005 · Cited by 1,738 · cited 1×
“…that DTI-derived axial diffusivity and radial diffusivity can concurrently quantify coexisting axonal injury and demyelination in some settings (Song et al., 2002, 2003, 2005), DTI becomes inaccurate in the presence of inflammation (Sun et al., 2006b; Lodygensky et al., 2010; Xie et al.,…”
Self-citationDemyelination increases radial diffusivity in corpus callosum of mouse brain
Song, S.-K., Yoshino, J., Le, T. Q., Lin, S.-J., Sun, S.-W., Cross, A. H., & Armstrong, R. C. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.01.028 · Cited by 1,658 · cited 2×
“Diffusion tensor imaging (DTI) derived axial diffusivity and radial diffusivity has been used to detect and distinguish axon and myelin abnormalities (Song et al., 2005; Kim et al., 2006; Sun et al., 2006a, b).”
Self-citationMoeller, S., Yacoub, E., Olman, C. A., Auerbach, E., Strupp, J., Harel, N., & Uğurbil, K. (2010) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22361 · Cited by 1,586 · cited 2×
“With emerging multi-band techniques (Moeller et al., 2010), DBSI scanning time will undoubtedly be further shortened, which would potentially allow higher spatial resolution and/or higher signal-to-noise ratio in future DBSI measurements.”
Deterministic diffusion fiber tracking improved by quantitative anisotropy
Yeh, F.-C., Verstynen, T. D., Wang, Y., Fernández-Miranda, J. C., & Tseng, W.-Y. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080713 · Cited by 1,121 · cited 1×
“DBSI-derived fibre orientation was colour-coded following the convention in the field using DSI Studio (http://dsi-studio.labsolver.org) (Yeh et al., 2013).”
Self-citationAbout “axial” and “radial” diffusivities
Wheeler‐Kingshott, C. A. M., & Cercignani, M. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21965 · Cited by 885
The peripheral benzodiazepine binding site in the brain in multiple sclerosis
Banati, R. B., Newcombe, J., Gunn, R. N., Cagnin, A., Turkheimer, F., Heppner, F., Price, G., Wegner, F., Giovannoni, G., Miller, D. H., et al. (2000) · Brain · doi:10.1093/brain/123.11.2321 · Cited by 661
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis
van Walderveen, M. A. A., Kamphorst, W., Scheltens, P., van Waesberghe, J. H. T. M., Ravid, R., Valk, J., Polman, C. H., & Barkhof, F. (1998) · Neurology · doi:10.1212/wnl.50.5.1282 · Cited by 656
Kappos, L., Moeri, D., Radue, E. W., Schoetzau, A., Schweikert, K., Barkhof, F., Miller, D., Guttmann, C. R., Weiner, H. L., Gasperini, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03053-0 · Cited by 499 · cited 2×
“…contrast agents in conjunction with T 1 -weighted MRI has been the primary clinical MRI tool for the detection of inflammation in multiple sclerosis through the detection of blood–brain barrier leakage (Grossman et al., 1988; Katz et al., 1993; Kappos et al., 1999; Vellinga et al., 2008).”
Sun, S., Liang, H., Trinkaus, K., Cross, A. H., Armstrong, R. C., & Song, S. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20774 · Cited by 461
Self-citationDiffusion tensor imaging of post mortem multiple sclerosis brain
Schmierer, K., Wheeler-Kingshott, C. A. M., Boulby, P. A., Scaravilli, F., Altmann, D. R., Barker, G. J., Tofts, P. S., & Miller, D. H. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.12.010 · Cited by 395
Katz, D., Taubenberger, J. K., Cannella, B., McFarlin, D. E., Raine, C. S., & McFarland, H. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340507 · Cited by 387
Quantification of increased cellularity during inflammatory demyelination
Wang, Y., Wang, Q., Haldar, J. P., Yeh, F.-C., Xie, M., Sun, P., Tu, T.-W., Trinkaus, K., Klein, R. S., Cross, A. H., et al. (2011) · Brain · doi:10.1093/brain/awr307 · Cited by 384
Self-citationHigh field MRI correlates of myelin content and axonal density in multiple sclerosis
Mottershead, J. P., Schmierer, K., Clemence, M., Thornton, J. S., Scaravilli, F., Barker, G. J., Tofts, P. S., Newcombe, J., Cuzner, M. L., Ordidge, R. J., et al. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0192-3 · Cited by 296
Detecting axon damage in spinal cord from a mouse model of multiple sclerosis
Kim, J. H., Budde, M. D., Liang, H.-F., Klein, R. S., Russell, J. H., Cross, A. H., & Song, S.-K. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.09.009 · Cited by 235 · cited 1×
“Diffusion tensor imaging (DTI) derived axial diffusivity and radial diffusivity has been used to detect and distinguish axon and myelin abnormalities (Song et al., 2005; Kim et al., 2006; Sun et al., 2006a, b).”
Self-citationVellinga, M. M., Oude Engberink, R. D., Seewann, A., Pouwels, P. J. W., Wattjes, M. P., van der Pol, S. M. A., Pering, C., Polman, C. H., de Vries, H. E., Geurts, J. J. G., et al. (2008) · Brain · doi:10.1093/brain/awn009 · Cited by 183
Xie, M., Tobin, J. E., Budde, M. D., Chen, C.-I., Trinkaus, K., Cross, A. H., McDaniel, D. P., Song, S.-K., & Armstrong, R. C. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181e3de90 · Cited by 175 · cited 4×
“…imaging (GQI) was recently proposed to estimate orientation distribution functions (ODF) directly from diffusion magnetic resonance signals based on the Fourier transform relation between diffusion weighted magnetic resonance signals and the underlying diffusion displacement (Yeh et al., 2010).”
InfluentialSelf-citationChiang, C.-W., Wang, Y., Sun, P., Lin, T.-H., Trinkaus, K., Cross, A. H., & Song, S.-K. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.06.064 · Cited by 141 · cited 7×
“We thus developed DBSI and have previously accurately captured the severity of axonal injury, demyelination, and inflammation in white matter tracts from mouse models of CNS inflammatory demyelination (Wang et al., 2011b, 2014; Chiang et al., 2014).”
InfluentialSelf-citationMR properties of excised neural tissue following experimentally induced inflammation
Stanisz, G. J., Webb, S., Munro, C. A., Pun, T., & Midha, R. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20008 · Cited by 138
Schmierer, K., Scaravilli, F., Barker, G. J., Gordon, R., MacManus, D. G., & Miller, D. H. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2003.00497.x · Cited by 35 · cited 1×
“Currently available quantitative MRI techniques have been validated using standard histology (Mottershead et al., 2003; Schmierer et al., 2003, 2004, 2007a, b; Fisniku et al., 2009).”
Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2
Cited by
Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?
Grussu, F., Schneider, T., Tur, C., Yates, R. L., Tachrount, M., Ianuş, A., Yiannakas, M. C., Newcombe, J., Zhang, H., Alexander, D. C., et al. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.445 · Cited by 312
Association between pathological and MRI findings in multiple sclerosis
Filippi, M., Brück, W., Chard, D., Fazekas, F., Geurts, J. J. G., Enzinger, C., Hametner, S., Kuhlmann, T., Preziosa, P., Rovira, À., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30451-4 · Cited by 253
Lazari, A., & Lipp, I. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.117744 · Cited by 197
An interactive meta-analysis of MRI biomarkers of myelin
Mancini, M., Karakuzu, A., Cohen-Adad, J., Cercignani, M., Nichols, T. E., & Stikov, N. (2020) · eLife · doi:10.7554/elife.61523 · Cited by 168
White matter alterations in early‐stage Alzheimer's disease: A tract‐specific study
Wen, Q., Mustafi, S. M., Li, J., Risacher, S. L., Tallman, E., Brown, S. A., West, J. D., Harezlak, J., Farlow, M. R., Unverzagt, F. W., et al. (2019) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.06.003 · Cited by 96
Metadata
- Authors
- Wang, Y., Sun, P., Wang, Q., Trinkaus, K., Schmidt, R. E., Naismith, R. T., Cross, A. H., & Song, S.-K.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-02-26
- Volume
- 138
- Issue
- 5
- Pages
- 1223-1238
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2168661252
- Cited by
- 162
- References
- 23
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.